DrugPatentWatch Database Preview
Try a free trial
See Plans and Pricing
« Back to Dashboard
Piqray is a drug marketed by Novartis Pharms Corp and is included in one NDA. There are two patents protecting this drug.
This drug has forty-seven patent family members in forty-one countries.
The generic ingredient in PIQRAY is alpelisib. One supplier is listed for this compound. Additional details are available on the alpelisib profile page.
Generic Entry Opportunity Date for PIQRAY
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Novartis Pharms Corp||PIQRAY||alpelisib||TABLET;ORAL||212526-001||May 24, 2019||RX||Yes||No||➤ Sign Up||➤ Sign Up||Y||Y||➤ Sign Up|
|Novartis Pharms Corp||PIQRAY||alpelisib||TABLET;ORAL||212526-003||May 24, 2019||RX||Yes||Yes||➤ Sign Up||➤ Sign Up||Y||Y||➤ Sign Up|
|Novartis Pharms Corp||PIQRAY||alpelisib||TABLET;ORAL||212526-002||May 24, 2019||RX||Yes||No||➤ Sign Up||➤ Sign Up||Y||Y||➤ Sign Up|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|